GlassScriptPhysician profile
Stephen T Amann
NPI 1063471761
$12,519.55
in general payments reported to CMS, 2019-2025
30 companies · $481 in 2025
The $481 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $393 · 2020: $120 · 2021: $3,152 · 2022: $1,067 · 2023: $6,559 · 2024: $748 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,750 · Food and Beverage: $2,422 · Travel and Lodging: $1,616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,750.00 |
| Food and Beverage | $2,422.38 |
| Travel and Lodging | $1,615.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $8,085.39 | 2021-2023 | |
| Abbvie INC. | $1,484.91 | 2019-2025 | Rinvoq, Skyrizi, Mavyret |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $422.03 | 2019-2025 | Xifaxan, Trulance, Plenvu |
| Takeda Pharmaceuticals U.S.A., INC. | $328.51 | 2019-2025 | Entyvio |
| Gilead Sciences, INC. | $256.10 | 2021-2025 | |
| Janssen Biotech, INC. | $241.35 | 2019-2024 | Stelara, Remicade, Simponi Aria |
| Boston Scientific Corporation | $214.83 | 2023-2025 | Watchman Flx, Therasphere Y90 Glass Microspheres 10 Gbq, Resolution 360 Ultra Clip |
| Genzyme Corporation | $209.23 | 2022-2025 | |
| Celgene Corporation | $143.34 | 2021-2024 | Zeposia |
| Ironwood Pharmaceuticals, INC | $123.98 | 2020-2023 | Linzess |
| Ardelyx, INC. | $112.44 | 2024-2025 | Ibsrela |
| Evoke Pharma, INC. | $110.87 | 2022-2023 | Gimoti |
| Nestle Healthcare Nutrition INC. | $104.02 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $95.55 | 2023-2024 | Dupixent |
| Pfizer INC. | $79.76 | 2019-2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $75.92 | 2022-2025 | Sucraid, Sucraid |
| Lilly USA, LLC | $62.69 | 2022-2023 | |
| Intercept Pharmaceuticals, INC. | $53.40 | 2021-2023 | Ocaliva |
| Merck Sharp & Dohme LLC | $44.44 | 2023 | Dificid |
| Biocompatibles, INC. | $41.88 | 2019 | |
| Aimmune Therapeutics, INC. | $40.88 | 2024-2025 | Zenpep |
| Amgen INC. | $39.19 | 2025 | Uplizna |
| Ipsen Biopharmaceuticals, INC | $34.42 | 2024-2025 | Iqirvo |
| Daiichi Sankyo INC. | $31.43 | 2019 | |
| Phathom Pharmaceuticals, INC. | $17.15 | 2024 | Voquezna |
| Romark Laboratories, Lc | $16.73 | 2020 | |
| Intra-Sana Laboratories | $16.01 | 2022 | |
| Ferring Pharmaceuticals INC. | $14.48 | 2019 | |
| Enterra Medical, INC. | $13.28 | 2022 | |
| Organon LLC | $5.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Amann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.